ReviewCurrent oncology reports2026

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Serafino LaGalbo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.